Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Non-Current Deferred Tax Liability of $17.1 million for Q1 2026, up 27.5% year-over-year from $13.4 million in Q1 2025, and up 11.0% quarter-over-quarter from $15.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $17.1 million in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $17.1 million, up 27.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.1 million (up 27.5% YoY), and the FY2025 annual result was $15.4 million, up 214.63% from the prior year.
- Non-Current Deferred Tax Liability improved to $17.1 million in Q1 2026 per STVN's latest filing, from $15.4 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $23.1 million in Q2 2023 and troughed at -$21.4 million in Q4 2022.
- A 5-year average of $11.0 million and a median of $14.6 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability slumped 53.27% in 2023, then surged 214.63% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at -$21.4 million in 2022, then jumped by 51.79% to -$10.3 million in 2023, then sank by 30.35% to -$13.5 million in 2024, then surged by 214.63% to $15.4 million in 2025, then advanced by 11.0% to $17.1 million in 2026.
- Business Quant data shows STVN's Non-Current Deferred Tax Liability at $17.1 million in Q1 2026, $15.4 million in Q4 2025, and $15.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.13 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Dec 31, 2023 | -10.33 Mn |
| Dec 31, 2023 | -10.33 Mn |